Our Technology
Asian Screening Array
Powerful and preferred genomic tool for Asians.
Simply put, the ASA was developed by American chip manufacturer, Illumina, to provide a more accurate and detailed analysis for the Asian population. Integrating its iScan® System and Infinium's High-Throughput Sequencing (HTS) technologies, ASA is able to detect over 750,000 gene loci and accounts for one of the highest efficacy rates. With its wide coverage of low-frequency mutations, we are able to detect mutation sites that are closely associated to onset of many diseases and traits.
By Asians. For Asians.
​
The ASA was developed from the data of over 9000 whole-genome sequences across Asia, including samples from Singapore, Malaysia, China, Japan, Korea, and many others. This provides a genomic tool that has a wide coverage of Asian population.
And we make it even better.
​
With this as a basis, our partner laboratories have added 50,000 biomarkers to include Y-SNPs, MT-SNPs and autosomal-related sites related to ancestry, complex diseases (such as cardiovascular and cerebrovascular diseases, metabolic diseases, mental diseases, tumours, etc.), genetic diseases, new-born birth defects, and other screening sites, including but not limited to personality characteristics and personal characteristics.
​
​
The result?
Targeted. Precise. Extensive. Analysis.